YL201 / MediLink  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
YL201 / MediLink
NCT06241846: A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPC

Recruiting
2
100
RoW
YL201 for Injection
MediLink Therapeutics (Suzhou) Co., Ltd.
Metastatic Castration-resistant Prostate Cancer (mCRPC)
02/27
02/29
NCT06057922: A Study YL201 in Patients With Selected Advanced Solid Tumors

Recruiting
1/2
640
RoW
YL201 for Injection
MediLink Therapeutics (Suzhou) Co., Ltd.
Advanced Solid Tumor
10/26
10/27

Download Options